Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

567

Figures (1-1)

Tables (1-1)

Sum=759

Publishing Process of This Article

Item

Count

Browse

Download

Sum=89

Aug 15, 2024 (publication date) through Oct 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Aug 15, 2024; 15(8): 1663-1671
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1663

Table 1 Medication-related information

Therapeutic drug	Anti-inflammatory properties	Risks
Insulin	Yes	Risk of hypoglycemia
SGLT-2 inhibitors	Yes	Risk of euglycemic diabetic ketoacidosis
DPP-4 inhibitors	Yes	Relatively safe
GLP-1 RA	Yes	Gastrointestinal symptoms
Metformin	Yes	Risk of lactic acidosis
Pioglitazone	Yes	Risk of fluid retention and heart failure

DPP-4: Dipeptidyl peptidase-4; GLP-1RA: Glucagon-like peptide-1 receptor agonist; SGLT-2: Sodium-glucose cotransporter-2.

Citation: Liu JW, Huang X, Wang MK, Yang JS. Diabetes and susceptibility to COVID-19: Risk factors and preventive and therapeutic strategies. World J Diabetes 2024; 15(8): 1663-1671
URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1663.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i8.1663